Article | August 9, 2021

Optimizing A Clinical Development Program To Improve ROI

Source: Advarra

By Steve Snapinn PhD, Managing Expert, Clinical Center of Excellence

biopharma and money

Clinical development proceeds in phases, and each phase contains a set of clinical trials. These trials, including their sample size calculations, are typically designed independently. However, there are advantages to considering the program as a whole and designing it to optimize the study’s return on investment (ROI). Below are some examples where considering ROI benefits individual study designs and the program overall.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: